Inventor · disambiguated record
Kristian Todd Poulsen
Also filed as: POULSEN KRISTIAN T · POULSEN KRISTIAN TODD
23 granted patents·19 pending applications·557 citations·filing 2006–2023
97Inventor score
Files withTEVA PHARMACEUTICALS INT GMBH19LABRYS BIOLOG INC13LABRYS BIOLOGICS INC3PFIZER2CORRADINI LAURA1
Top patents by PatentIndex Score
42 records- 0198US8734802B1Methods of treating vasomotor symptoms using antibodiesLABRYS BIOLOG INC·Filed 2013·Granted May 27, 2014·54 cites·20 claims
- 0298US8597649B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameLABRYS BIOLOG INC·Filed 2013·Granted Dec 3, 2013·51 cites·9 claims
- 0397US9884907B2Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Feb 6, 2018·15 cites·18 claims
- 0497US9884908B2Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Feb 6, 2018·15 cites·18 claims
- 0597US9346881B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameLABRYS BIOLOG INC·Filed 2015·Granted May 24, 2016·16 cites·19 claims
- 0697US9340614B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameLABRYS BIOLOG INC·Filed 2015·Granted May 17, 2016·16 cites·20 claims
- 0797US9266951B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameLABRYS BIOLOG INC·Filed 2015·Granted Feb 23, 2016·23 cites·19 claims
- 0897US9115194B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameLABRYS BIOLOG INC·Filed 2014·Granted Aug 25, 2015·26 cites·20 claims
- 0997US8007794B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameRINAT NEUROSCIENCE CORP·Filed 2006·Granted Aug 30, 2011·51 cites·9 claims
- 1096US9890210B2Antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Feb 13, 2018·11 cites·15 claims
- 1196US9890211B2Antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Feb 13, 2018·11 cites·15 claims
- 1296US9365648B1Methods of using anti-CGRP antagonist antibodiesLABRYS BIOLOG INC·Filed 2016·Granted Jun 14, 2016·16 cites·29 claims
- 1396US9328168B2Methods of using anti-CGRP antagonist antibodiesLABRYS BIOLOG INC·Filed 2015·Granted May 3, 2016·16 cites·30 claims
- 1496US8586045B2Methods of using anti-CGRP antagonist antibodiesZELLER JOERG·Filed 2011·Granted Nov 19, 2013·61 cites·31 claims
- 1594US8293239B2Methods of treating chronic painPOULSEN KRISTIAN TODD·Filed 2009·Granted Oct 23, 2012·51 cites·14 claims
- 1693US10329343B2Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2018·Granted Jun 25, 2019·5 cites·24 claims
- 1793US9328167B2Methods of treating chronic painLABRYS BIOLOG INC·Filed 2015·Granted May 3, 2016·11 cites·20 claims
- 1893US8623366B2Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptidePIOS ARIEL ATES·Filed 2010·Granted Jan 7, 2014·49 cites·19 claims
- 1993US8298536B2Methods of treating inflammatory painCORRADINI LAURA·Filed 2009·Granted Oct 30, 2012·52 cites·14 claims
- 2090US2024158481A1Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using SameTEVA PHARMACEUTICALS INT GMBH·Filed 2023·Application pending·0 cites
- 2187US11421040B2Antibodies specific for FLT3 and their usesPFIZER·Filed 2018·Granted Aug 23, 2022·5 cites·14 claims
- 2279US10323085B2Methods of treating fibromyalgiaTEVA PHARMACEUTICALS INT GMBH·Filed 2018·Granted Jun 18, 2019·1 cites·18 claims
- 2379US2022056114A1Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using SameTEVA PHARMACEUTICALS INT GMBH·Filed 2021·Application pending·0 cites
- 2478US2020247878A1Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using SameTEVA PHARMACEUTICALS INT GMBH·Filed 2019·Application pending·0 cites
- 2577US10597448B2Methods for treating visceral pain associated with interstitial cystitis by administering antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2018·Granted Mar 24, 2020·1 cites·6 claims
- 2674US2021317196A1Methods of Treating Chronic PainTEVA PHARMACEUTICALS INT GMBH·Filed 2020·Application pending·0 cites
- 2774US2022017608A1Methods of Treating Inflammatory PainTEVA PHARMACEUTICALS INT GMBH·Filed 2021·Application pending·0 cites
- 2872US2019092841A1Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using SameTEVA PHARMACEUTICALS INT GMBH·Filed 2018·Application pending·0 cites
- 2970US2020148752A1Methods of Treating Inflammatory PainTEVA PHARMACEUTICALS INT GMBH·Filed 2019·Application pending·0 cites
- 3070US2021047397A1Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2020·Application pending·0 cites
- 3168US2020087384A1Methods of treating chronic painTEVA PHARMACEUTICALS INT GMBH·Filed 2019·Application pending·0 cites
- 3266US2017081395A1Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameTEVA PHARMACEUTICALS INT GMBH·Filed 2016·Application pending·0 cites
- 3364US12202910B2Antibodies specific for FLT3 and their usesPFIZER·Filed 2022·Granted Jan 21, 2025·0 cites·8 claims
- 3463US2014308290A1Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptideLABRYS BIOLOG INC·Filed 2014·Application pending·0 cites
- 3562US2018305443A1Methods of Treating Inflammatory PainTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Application pending·0 cites
- 3662US2013295087A1Methods of treating chronic painLABRYS BIOLOG INC·Filed 2013·Application pending·0 cites
- 3761US2013295088A1Methods of treating inflammatory painLABRYS BIOLOG INC·Filed 2013·Application pending·0 cites
- 3861US2017275352A1Methods of Treating Chronic PainTEVA PHARMACEUTICALS INT GMBH·Filed 2016·Application pending·0 cites
- 3961US2014314767A1Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptideLABRYS BIOLOG INC·Filed 2013·Application pending·0 cites
- 4059US2017044243A1Methods of treating chronic painLABRYS BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 4157US2017073398A1Methods of treating inflammatory painLABRYS BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 4256US2017073412A1Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptideLABRYS BIOLOGICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kristian Todd Poulsen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →